Revolutionizing lupus care with breakthroughs in proteomics and digital health.
What is aiSLE MGMT?
aiSLE MGMT is a lupus management platform that provides clinicians with unparalleled insight into lupus disease activity and the patient's experience. It combines two new technologies -- both powered by artificial intelligence:
- Immunologic Data
- Patient-Generated Data
Identify lupus flare risk up to 12 weeks in advance with a new blood test, aiSLE™ DX, that analyzes changes in immune system biomarkers and pathways
Understand the ups and downs of the patient journey between clinic visits with [AutoimmuneCorner]™, a mobile app & wearable device used by patients
aiSLE MGMT
Patient Out-of-Pocket Costs
Healthcare costs should be affordable and understandable.
To achieve these goals, we launched aiSLE™ Access For All, a financial support program. Following insurance adjudications, the aiSLE MGMT Customer Success Team will work with patients to reduce their out-of-pocket responsibility.
In most cases, patients out-of-pocket costs are $50 or less. Many patients are eligible to receive all features of aiSLE MGMT, including health coaching, at no additional cost as part of an introductory offer.
aiSLE MGMT is available to people covered by Medicare and most private insurers.
How it works
- Order aiSLE MGMT for your SLE patients
- The aiSLE MGMT Patient Success Team gets the patient started on [AutoimmuneCorner]
- Onboard them to the app
- Schedule their first health coach session
- Deliver the Withings Steel HR smartwatch
- Receive a synthesized clinical report
- Re-order aiSLE MGMT at the patient's next visit to continue quarterly aiSLE DX lab testing and [AutoimmuneCorner] patient access
Collect the patient's blood sample using the aiSLE DX test kit. Fill out the aiSLE MGMT requisition and return it with the blood sample.
We contact the patient directly to:
After the blood sample is analyzed, you will receive a laboratory result report via fax.
Plus, the aiSLE MGMT Report which features patient data from the app, will be provided monthly.
Exploring the technologies
aiSLE DX
The first proactive test for lupus (SLE). Identify the risk of experiencing a lupus flare in the next 12 weeks.
[AutoimmuneCorner]
Just the app to help patients take on lupus. [AC] offers tools to keep patients on track and docs in the loop.
Sample Source
Blood
Results Reported
- Flare Risk Index
(algorithm-derived risk score) - Immunologic measures of eleven cytokines
Monthly Report features
- Health coaching notes and messages
- Wearable device data including activity, sleep depth and quality, and heart rate
- Lupus symptom and flare tracking logs
- Standardized patient-reported outcome (PRO) measures including SLEQOL and VAS (pain, fatigue)
Exploring the technologies
aiSLE™ DX Flare Risk Index
The first proactive blood test for lupus (SLE). Identify the risk of experiencing a lupus flare in the next 12 weeks.
Laboratory result
- Risk score derived from artificial intelligence algorithm
- Immunologic measures of eleven cytokines
[AutoimmuneCorner]
Just the app to help you take on lupus. In addition to lupus tracking tools and health education, you get access to video and messaging sessions with a health coach. Plus, use the included Withings Steel HR smartwatch to track the quality of your sleep and activity.
Digital Data
- Health coaching notes and messages
- Wearable device data including activity, sleep depth and quality, and heart rate from Withings Steel HR smartwatch
- Lupus symptom and flare tracking logs
- Standardized patient-reported outcome (PRO) measures
For people living with
Systemic Lupus Erythematosus (SLE)
Explore the validation and development efforts
Test Accuracy
The Odds Ratio (OR) calculated for pre-flare vs pre-nonflare patients with positive vs. negative score approaches 5.0 and is highly significant (p= 0.0015). This OR indicates that a patient with a positive aiSLE DX Flare Risk Index score is almost 5 times more likely to flare than a patient with a negative score.
Test Development
aiSLE™ DX Flare Risk Index was developed through clinical studies conducted at several National Institutes of Health-designated Autoimmunity Centers of Excellence in the United States. Participants in the clinical studies contributed blood samples and had their lupus flare status assessed by a rheumatologist using the SLEDAI, the gold standard for assessing a lupus patient’s current disease activity.
People of diverse racial and ethnic backgrounds participated in the studies including European Americans, African Americans, and Native Americans.
About the Progentec Laboratory
The Progentec laboratory is both CLIA-certified & CAP-accredited. It is based in Oklahoma City at the Oklahoma Medical Research Foundation. Our lab team has over 50 years of lab operations experience and can provide insight into best practices regarding cost-effective, accurate testing.